Browse by Countries

Request/Offer Detail

Title: Anti-EpCAM Immunocytokine, IgG (LSLS-ATAT) (huKS)-IL2
TypeName: Business Offer
Request Date:2017/07/31
Country: Afghanistan
Summary: This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-EpCAM IgG (LSLS-ATAT) to IL2. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the EpCAM as well as the biological activity of IL2. Modification of amino acid residues at the junction of immunocytokine fusion proteins to reduce immunogenicity by identifying candidate T-cell epitopes.
Description: This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-EpCAM IgG (LSLS-ATAT) to IL2. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the EpCAM as well as the biological activity of IL2. Modification of amino acid residues at the junction of immunocytokine fusion proteins to reduce immunogenicity by identifying candidate T-cell epitopes. This immunocytokine was designed for treating solid tumor. http://www.creativebiolabs.net/Anti-EpCAM-Immunocytokine-IgG-LSLS-ATAT-huKS-IL2-22504.htm
Advantages:
Comments:
RequestId: 390
Name:Creative Biolabs
Telphone:
Email:marketing@creative-biolabs.com

Sponsors

smartportal sponsors